Related Experiment Video

Updated: May 14, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

Stromal cell-induced miRNA alteration in chronic lymphocytic leukemia: how a minute and unavoidable cell

J Paggetti, G Berchem, E Moussay

    Leukemia
    |February 15, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
    07:23

    Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

    Published on: June 15, 2016

    Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
    11:06

    Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

    Published on: September 20, 2017

    Related Experiment Videos

    Last Updated: May 14, 2026

    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
    08:14

    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

    Published on: October 26, 2017

    Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
    07:23

    Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

    Published on: June 15, 2016

    Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
    11:06

    Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

    Published on: September 20, 2017

    Related Concept Videos

    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

    Articles linked to this work by shared authors, journal, and citation graph.

    Helicobacter pylori prevalence and antibiotic resistance in patients undergoing bariatric surgery in Luxembourg: Impact and implications.

    Acta gastro-enterologica Belgica·2026

    Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

    Nature communications·2025

    Case Report: Primary Spinal Lymphoma.

    Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg·2018

    Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014

    Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia.

    Leukemia·2014

    [Giant melanoma of the scalp: Case report].

    Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg·2013

    Clinical evaluation of AI-assisted quantitative marrow fibrosis assessment using Continuous Indexing of Fibrosis (CIF).

    Leukemia·2026

    Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

    Leukemia·2026

    Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

    Leukemia·2026

    Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia.

    Leukemia·2026

    Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

    Leukemia·2026

    Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy.

    Leukemia·2026

    RNA virome comparison between sylvatic and urban-interface mosquitoes from Southeastern Brazil.

    Frontiers in cellular and infection microbiology·2026

    Mpox in the Republic of Korea from 2022 to June 2026: Epidemiological Trends and the First Clade Ib Case.

    Public health weekly report·2026

    Cardiac MRI-guided therapeutics in ischemic cardiomyopathy: impact on heart-team consensus and outcomes.

    Frontiers in cardiovascular medicine·2026

    Re-evaluating variability of circulating miR-122 in healthy volunteers: Implications for biomarker qualification in drug-induced liver injury.

    British journal of clinical pharmacology·2026

    Divergent host adaptation in Marburg virus: a hypothesis-generating framework for prioritizing non-traditional reservoirs.

    BMC genomics·2026

    MicroRNA-122 as a regulator and biomarker of liver disease.

    Journal of molecular medicine (Berlin, Germany)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us